TransMedics Group Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? TransMedics Group Inc trades at $79.01 (market cap $2.74B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.61 (market cap $330.98M). The key difference: TransMedics Group Inc is far larger — about 8.3× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| TMDX | XDTE | |
|---|---|---|
Market Cap | $2.74B | $330.98M |
Volume | 949,331 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $150.42 | $44.76 |
52-Week Low | $61.99 | $36.00 |
Typical Hold Time | 24 Days | 54 Days |
Enterprise Value | $3.13B | — |
Signals from Pluang's Aura AI — not financial advice
TMDX trades at $81.07, up 0.98% today, but faces a bearish technical signal with recent price weakness. Fundamentally, the company reported strong 2025 results with $605.49M revenue and $190.29M net income, though 2026 projections show margin compression. Recent news highlights insider buying and ongoing legal investigations into fiduciary duties, creating mixed sentiment.
The stock offers potential upside to the $99.75 consensus target, supported by a 69% buy rating from analysts, but risks include earnings misses, margin pressure from heavy investment, and legal overhangs. Execution on growth amid rising costs remains critical for sustaining its premium valuation.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →